跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
速碧林 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Nadroparin Calcium Injection
Approved
化学药品
Nadroparin Calcium Injection
ASPEN PHARMA TRADING LIMITED
🇨🇳 National Medical Products Administration
Approval Date
Jul 24, 2023
Approval ID
8TEMEB5SDqE
Company
ASPEN PHARMA TRADING LIMITED
Type
化学药品
Approval Details
Approval Id
8TEMEB5SDqE
Approval Number
国药准字HJ20181135
Generic Name
那屈肝素钙注射液
Generic Name En
Nadroparin Calcium Injection
Trade Name
速碧林
Drug Type
化学药品
Dosage Form
注射剂
Strength
0.3ml:2850AXaIU
Reg Date
2023-07-24
Expired Date
2028-06-28
Company Name
ASPEN PHARMA TRADING LIMITED
Production Company Name
ASPEN NOTRE DAME DE BONDEVILLE
Company Detail Path
/organization/aspen-pharma-trading-limited
Production Company Detail Path
/organization/aspen-notre-dame-de-bondeville
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 24, 2023
Approval ID
8TEMEB5SDqE
Type
化学药品
Back to NMPA Approvals